Screening to Prevent Heart Failure (STOP-HF): Expanding the Focus Beyond Asymptomatic Left Ventricular Systolic Dysfunction

Abstract

A significant number of patients at risk for LVSD and labelled false positive with screening were found to have LVDD. Identifying this at-risk cohort may improve outcomes, but the clinical and economic benefit of this screening strategy requires formal assessment.